CLINICAL_TRIALS
trial_result
· 2026-02-25
Clinical Trial Update: Raltitrexed in HIPEC [Phase 1]
Summary
A Phase 1 trial evaluating raltitrexed in HIPEC for colorectal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fudan University | Conditions: Colorectal Cancer, Raltitrexed | Phase 1 | Status: COMPLETED